Cargando…

High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma

Currently there are no molecular markers able to predict clinical outcome in locally advanced head and neck squamous cell carcinoma (HNSCC). In a previous microarray study, RAB25 was identified as a potential prognostic marker. The aim of this study was to analyze the association between RAB25 expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Téllez-Gabriel, Marta, Arroyo-Solera, Irene, León, Xavier, Gallardo, Alberto, López, Montserrat, Céspedes, Maria V, Casanova, Isolda, López-Pousa, Antonio, Quer, Miquel, Mangues, Maria A, Barnadas, Agustí, Mangues, Ramón, Pavón, Miguel A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892400/ https://www.ncbi.nlm.nih.gov/pubmed/24403269 http://dx.doi.org/10.1002/cam4.153

Ejemplares similares

Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients
por: Pavón, Miguel Angel, et al.
Publicado: (2015)

uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy
por: Pavón, Miguel Angel, et al.
Publicado: (2016)

Subcutaneous preconditioning increases invasion and metastatic dissemination in mouse colorectal cancer models
por: Alamo, Patricia, et al.
Publicado: (2014)

A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models
por: Falgàs, Aïda, et al.
Publicado: (2020)

Selective depletion of metastatic stem cells as therapy for human colorectal cancer
por: Céspedes, María Virtudes, et al.
Publicado: (2018)

CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4(+) head and neck squamous cell carcinoma tumors
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis
por: Moreno, María José, et al.
Publicado: (2018)

Efficient bioactive oligonucleotide‐protein conjugation for cell‐targeted cancer therapy
por: Aviñó, Anna, et al.
Publicado: (2019)

Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease
por: Medina-Gutiérrez, Esperanza, et al.
Publicado: (2022)

GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases
por: Sala, Rita, et al.
Publicado: (2022)

NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients
por: Pallarès, Victor, et al.
Publicado: (2017)

Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4(+) Diffuse Large B-Cell Lymphoma Cells
por: Falgàs, Aïda, et al.
Publicado: (2021)

Intracellular CXCR4(+) cell targeting with T22-empowered protein-only nanoparticles
por: Unzueta, Ugutz, et al.
Publicado: (2012)

Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models
por: Medina-Gutiérrez, Esperanza, et al.
Publicado: (2022)

Selective delivery of T22-PE24-H6 to CXCR4(+) diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
por: Falgàs, Aïda, et al.
Publicado: (2020)

T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
por: Núñez, Yáiza, et al.
Publicado: (2023)

Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia
por: Pallarès, Victor, et al.
Publicado: (2018)

Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors
por: Mira, Alessia, et al.
Publicado: (2017)

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models
por: Céspedes, María Virtudes, et al.
Publicado: (2016)

Artificial Inclusion Bodies for Clinical Development
por: Sánchez, Julieta M., et al.
Publicado: (2019)

Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles
por: Álamo, Patricia, et al.
Publicado: (2020)

An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
por: Pallarès, Victor, et al.
Publicado: (2020)

Targeting in Cancer Therapies
por: Mangues, Ramon, et al.
Publicado: (2016)

Time-Prolonged Release of Tumor-Targeted Protein–MMAE Nanoconjugates from Implantable Hybrid Materials
por: Serna, Naroa, et al.
Publicado: (2022)

Surgery of basal cell carcinoma around the lacrimal canaliculus can be necessary after primary treatment with intralesional interferon alpha 2b
por: Huerva, V, et al.
Publicado: (2008)

Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4(+) Cancers
por: Cano-Garrido, Olivia, et al.
Publicado: (2021)

Ion-dependent slow protein release from in vivo disintegrating micro-granules
por: Álamo, Patricia, et al.
Publicado: (2021)

Patients’ Perspective of Medication Adherence in Chronic Conditions: A Qualitative Study
por: Pagès-Puigdemont, Neus, et al.
Publicado: (2016)

Prevalence and clinical impact of recreational drug consumption in people living with HIV on treatment: a cross-sectional study
por: Garin, Noe, et al.
Publicado: (2017)

Recombinant pharmaceuticals from microbial cells: a 2015 update
por: Sanchez-Garcia, Laura, et al.
Publicado: (2016)

Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins
por: Álamo, Patricia, et al.
Publicado: (2023)

Cefepime Dosing Requirements in Elderly Patients Attended in the Emergency Rooms
por: Ruiz-Ramos, Jesus, et al.
Publicado: (2022)

KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma
por: Liu, Yi, et al.
Publicado: (2020)

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli
por: Rueda, Fabián, et al.
Publicado: (2016)

Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: A prospective observational study
por: Solá, Montserrat, et al.
Publicado: (2011)

Rab25 GTPase: Functional roles in cancer
por: Wang, Sisi, et al.
Publicado: (2017)

Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations
por: Garin, Noe, et al.
Publicado: (2015)

Corrigendum: Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations
por: Garin, Noe, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gb5dd5n1mptnqijoe8nu2vrv5l